Growth Metrics

Boston Scientific (BSX) Depreciation and Depletion (2020 - 2026)

Boston Scientific's Depreciation and Depletion history spans 7 years, with the latest figure at $29.0 million for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion rose 7.41% to $29.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $394.0 million, a 12.89% increase, with the full-year FY2025 number at $471.0 million, up 14.32% from a year prior.
  • Depreciation and Depletion hit $29.0 million in Q1 2026 for Boston Scientific, down from $137.0 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for BSX hit a ceiling of $137.0 million in Q4 2025 and a floor of $27.0 million in Q1 2025.
  • Historically, Depreciation and Depletion has averaged $90.2 million across 5 years, with a median of $93.0 million in 2023.
  • Biggest five-year swings in Depreciation and Depletion: increased 17.31% in 2024 and later tumbled 70.0% in 2025.
  • Tracing BSX's Depreciation and Depletion over 5 years: stood at $95.0 million in 2022, then rose by 9.47% to $104.0 million in 2023, then increased by 17.31% to $122.0 million in 2024, then increased by 12.3% to $137.0 million in 2025, then tumbled by 78.83% to $29.0 million in 2026.
  • Business Quant data shows Depreciation and Depletion for BSX at $29.0 million in Q1 2026, $137.0 million in Q4 2025, and $117.0 million in Q3 2025.